Natural Product: NPC281258

Natural Product IDNPC281258
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
6-Hydroxymexicanolide
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2272737
PubChem CID 60200692
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey XEHMUYDSKXRHFC-POLOUJCESA-N
Standard InCHI InChI=1S/C27H32O8/c1-25(2)20(19(29)24(32)33-5)27(4)16-6-8-26(3)17(14(16)10-15(21(25)30)22(27)31)11-18(28)35-23(26)13-7-9-34-12-13/h7,9,12,15-16,19-20,23,29H,6,8,10-11H2,1-5H3/t15-,16-,19+,20-,23-,26+,27+/m0/s1
SMILES COC(=O)[C@@H]([C@H]1C(C)(C)C(=O)[C@H]2C(=O)[C@]1(C)[C@H]1CC[C@@]3(C(=C1C2)CC(=O)O[C@H]3c1ccoc1)C)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   484.21 Volume:   484.632
?
Van der Waals volume.
Dense:   0.999 LogP:   1.359
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.63
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.122
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   4.0 Rigid Bonds:   29.0
TPSA:   120.11
?
Topological Polar Surface Area.
H-Bond Acceptor:   8.0
H-Bond Donor:   1.0 Rings:   5.0
Heavy Atoms:   8.0

MedChem Properties

QED Drug-Likeness Score:   0.394 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.931 Fsp3:   0.63
MCE-18:   126.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.773 Fluc inhibitor:   0.001
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.24
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.011
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.019 Promiscuous compounds:   0.12

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.36 MDCK Permeability:   -4.936
Pgp-inhibitor:   0.256 Pgp-substrate:   0.082
PAMPA:   0.705
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.036 30% Bioavailability (F30%):   0.02
50% Bioavailability (F50%):   0.317

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.002 MRP1:   0.996
Plasma Protein Binding (PPB):   92.602% Volume Distribution (VD):   0.181
Fu: 6.365%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.366
OATP1B3 inhibitor:   0.967 BCRP inhibitor:   0.033
BSEP inhibitor:   0.99

ADMET: Metabolism

CYP1A2-inhibitor:   0.046 CYP1A2-substrate:   0.1
CYP2C19-inhibitor:   0.359 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.372
CYP3A4-inhibitor:   0.998 CYP3A4-substrate:   0.609
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.65
HLM stability:   0.914
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.613 Half-life (T1/2):  1.102

ADMET: Toxicity

hERG Blockers:  0.012 hERG Blockers (10um):  0.064
Human Hepatotoxicity (H-HT):  0.747 Drug-induced Liver Injury (DILI):  0.97
AMES Toxicity:  0.365 Rat Oral Acute Toxicity:  0.782
Maximum Recommended Daily Dose:  0.633 Skin Sensitization:  0.96
Carcinogencity:  0.54 Eye Corrosion:  0.0
Eye Irritation:  0.835 Respiratory Toxicity:  0.237
Drug-induced Neurotoxicity:  0.296 Ototoxicity:  0.578
Hematotoxicity:  0.452 Drug-induced Nephrotoxicity:  0.953
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.13
A549 Cytotoxicity:  0.057 Hek293 Cytotoxicity:  0.115
BCF:   0.609
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.407
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.424
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.711
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[20112995]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[20146503]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds Thai n.a. PMID[21733687]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[22724531]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[26114936]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT4696 Organism Brontispa longissima Brontispa longissima Activity = 20.7 % DrugMatrix in vitro pharmacology data
NPT4696 Organism Brontispa longissima Brontispa longissima Activity = 69.3 % PMID[10924165]
NPT4696 Organism Brontispa longissima Brontispa longissima Activity = 76.6 % PMID[15497934]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC281258 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7639 Intermediate Similarity NPC142113
0.7342 Intermediate Similarity NPC69028
0.6582 Remote Similarity NPC178932
0.6279 Remote Similarity NPC276551
0.619 Remote Similarity NPC606471
0.6136 Remote Similarity NPC470875
0.5833 Remote Similarity NPC263432
0.5714 Remote Similarity NPC469503
0.5581 Remote Similarity NPC292389
0.5529 Remote Similarity NPC475779
0.5455 Remote Similarity NPC469338
0.5333 Remote Similarity NPC469849

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC281258 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data